The evidence of new obesity and diabetes drugs' smashing success can now be seen in grocery store aisles.
Why it matters: Food giants are rolling out new and reformulated products appealing to the changing appetites of the fast-growing number of people prescribed drugs like Novo Nordisk's Ozempic and Wegovy — and experts say this could shift American diets more broadly.
